HeraMED's Strategic Partnership with Founda Health

HeraMED Limited (ASX:HMD) has executed a Letter of Intent ('LOI') to enter into a strategic partnership with Founda Health B.V. ('Founda'). Founda Health, a leading healthcare integration platform provider, aims to revolutionize healthcare ICT by facilitating seamless data availability between health applications and systems. Through this potential partnership, HeraMED will utilize Founda's platform to seamlessly integrate its HeraCARE solution with EHR within hospital systems, ensuring expectant mothers receive the highest quality care.

Executive Commentary on the Partnership

Wilco Schuttelaar, Co-Founder of Founda, expressed excitement about the partnership, stating, 'We look forward to partnering with HeraMED to advance the digitalization of maternity care. Our platform is designed to overcome the interoperability challenges in healthcare, and by working together, we can ensure that HeraMED's solutions are easily accessible to healthcare providers and patients alike.' HeraMED's Chief Executive Officer and Managing Director, Anoushka Gungadin, also expressed enthusiasm about the potential partnership, highlighting the seamless integration of their innovative maternity care solutions with hospital systems and the potential to materially advance their mission to revolutionize maternity care.

Summary of HeraMED's Strategic Partnership

HeraMED (ASX:HMD) has signed a Letter of Intent ('LOI') with Founda Health B.V. ('Founda') as a precursor to a strategic partnership. The potential partnership aims to revolutionize maternity care by seamlessly integrating HeraMED's HeraCARE solution with EHR within hospital systems, leveraging Founda's powerful interoperability platform. This aligns with HeraMED's growth plan, focusing on expanding market reach, global promotion, enhanced interoperability, and collaborative innovation. The partnership is expected to accelerate HeraMED's market expansion efforts, increase visibility, improve integration capabilities, and strengthen their product portfolio. The company will provide further updates as the partnership progresses from LOI to a definitive agreement.